Bright Minds Biosciences DRUG
NASDAQ DRUG
$23.45 +0.84 (+3.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Bright Minds Biosciences (DRUG) Other Non-Current Liabilities (2022 - 2024)

Updated

Bright Minds Biosciences' Other Non-Current Liabilities was $9,412 in fiscal Q3 2022 (quarter ended Jun 30, 2022).

Analysis

Bright Minds Biosciences (DRUG) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 337,241.66
Jun 30, 2024 607,209.14
Mar 31, 2024 614,534.56
Dec 31, 2023 628,767.28
Sep 30, 2023 616,584.39
Jun 30, 2023 627,799.21
Mar 31, 2023 615,175.39
Dec 31, 2022 613,808.99
Jun 30, 2022 9,314.38
API Access

Bright Minds Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=DRUG&period=max&api_key=YOUR_API_KEY